Filing Details

Accession Number:
0001144204-14-070780
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-25 08:00:29
Reporting Period:
2014-11-21
Filing Date:
2014-11-25
Accepted Time:
2014-11-25 08:00:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369868 China Biologic Products Inc. CBPO Biological Products, (No Disgnostic Substances) (2836) 752308816
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1575517 Cbpo Zhijing Liu 18Th Floor, Jialong International
Building, 19 Chaoyang Park Road
Beijing F4 100125
Corporate Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-21 8,000 $12.26 11,036 No 4 M Direct
Common Stock Disposition 2014-11-21 8,000 $68.95 3,036 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-11-21 8,000 $0.00 8,000 $12.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,500 2010-10-11 2020-07-11 No 4 M Direct
Footnotes
  1. Represents 8,000 shares of common stock (the "Sold Common Stock") sold on the open market for $68.95 per share on November 21, 2014. The Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 2 below for further details on the relevant stock options.
  2. Represents previously reported stock options to purchase 8,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated July 11, 2010. The options were scheduled to vest in 12 equal portions on a quarterly basis over a three-year period, with the initial vesting date being October 11, 2010, provided that the Reporting Person is employed by the Issuer on each vesting date.
  3. Includes the balance of the previously reported stock options to purchase 15,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012.